Walleye Trading’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,500
Closed -$52.1K 4354
2025
Q1
$52.1K Sell
5,500
-9,300
-63% -$93.9K ﹤0.01% 3601
2024
Q4
$167K Sell
14,800
-1,900
-11% -$33.4K ﹤0.01% 3315
2024
Q3
$472K Buy
16,700
+2,700
+19% +$69.6K ﹤0.01% 2547
2024
Q2
$268K Buy
+14,000
New +$358K ﹤0.01% 2909
2024
Q1
Sell
-11,900
Closed -$393K 4923
2023
Q4
$393K Buy
+11,900
New +$337K ﹤0.01% 3273
2022
Q4
Sell
-7,200
Closed -$259K 5075
2022
Q3
$259K Buy
+7,200
New +$254K ﹤0.01% 3475
2022
Q1
Sell
-8,700
Closed -$241K 5472
2021
Q4
$241K Sell
8,700
-2,800
-24% -$80.3K ﹤0.01% 3705
2021
Q3
$357K Buy
11,500
+6,900
+150% +$166K ﹤0.01% 3283
2021
Q2
$97K Sell
4,600
-13,700
-75% -$274K ﹤0.01% 4390
2021
Q1
$370K Buy
18,300
+14,500
+382% +$276K ﹤0.01% 3004
2020
Q4
$61K Buy
+3,800
New +$50.2K ﹤0.01% 4123
2019
Q1
Sell
-7,000
Closed -$140K 4358
2018
Q4
$140K Buy
7,000
+6,400
+1,067% +$148K ﹤0.01% 3680
2018
Q3
$17K Buy
+600
New +$14.3K ﹤0.01% 4890
2018
Q2
Sell
-10,700
Closed -$152K 4647
2018
Q1
$152K Buy
+10,700
New +$153K ﹤0.01% 3683

Other funds holding EVH

Walleye Trading's EVH Position: Q3 2025 in Review

Walleye Trading sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 65,757 shares — an estimated $638K sold.

Walleye Trading first reported a position in EVH in Q1 2018 and held it in 14 quarters. The position peaked at $740K in Q2 2025. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Walleye Trading reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 65,757 Evolent Health shares in Q3 2025, an estimated $638K.
  • Walleye Trading first reported a position in Evolent Health in Q1 2018 and held it in 14 quarters.
  • Walleye Trading's Evolent Health position peaked at $740K in Q2 2025.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.